December 05, 2019
The federal government has urged the U.S. Supreme Court to take on a case challenging an Arkansas law regulating pharmacy benefit managers' drug reimbursement rates, arguing that the Eighth Circuit wrongly held the statute was trumped by the Employee Retirement Income Security Act.
November 27, 2019
Some states have responded to rising health care costs and dwindling retirement savings by passing legislation, triggering challenges from business groups and others who say those statutes are trumped by federal benefits law. Here, Law360 looks back at three ERISA preemption disputes from 2019 that attorneys should have on their radar.
October 04, 2019
As the U.S. Supreme Court kicks off its new term Monday, the justices are poised to take on health care cases involving some of the most controversial policy issues in the country, including abortion rights and the Affordable Care Act. Here, Law360 takes a look at a quintet of major battles to watch.
April 15, 2019
The U.S. Supreme Court asked the U.S. solicitor general Monday to weigh in on Arkansas' battle with a trade group over whether a state law regulating pharmacy benefit managers' drug reimbursement rates is preempted by the Employee Retirement Income Security Act.
March 20, 2019
Arkansas again urged the U.S. Supreme Court to consider whether the Employee Retirement Income Security Act preempted a state law regulating pharmacy benefit managers' drug reimbursement rates, rebutting arguments that the case wasn't a good instrument for addressing the issue.
March 01, 2019
The pharmacy benefit management industry has asked the U.S. Supreme Court to pass on Arkansas' attempt to revive a state law regulating PBMs, claiming the petition had too many flaws to let the justices truly focus on whether the law was preempted by the Employee Retirement Income Security Act.
November 26, 2018
California, Texas and 30 other states have thrown their weight behind Arkansas in its fight to get the U.S. Supreme Court to undo an Eighth Circuit ruling that prevented the state from regulating pharmacy benefit managers' drug reimbursement rates.